Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 19c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($1.06), $0.19 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $63 million versus the consensus estimate of $51.58 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• KB Home (KBH) PT Lowered to $50 at RBC Capital
• KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)